One of the most commonly used models for preclinical testing was developed by Cichowski et al. and Vogel et al; they demonstrated that mice with germline variants in Nf1 and Tp53 develop MPNSTs, supporting a cooperative and causal role for these tumor suppressors in the context of MPNST formation [14,15]. This evidence concerns the gene NF1 and neoplasm.